198 related articles for article (PubMed ID: 25291526)
21. Pancreatic neuroendocrine tumors: Therapeutic challenges and research limitations.
Mpilla GB; Philip PA; El-Rayes B; Azmi AS
World J Gastroenterol; 2020 Jul; 26(28):4036-4054. PubMed ID: 32821069
[TBL] [Abstract][Full Text] [Related]
22. The predictive value of mean platelet volume in differential diagnosis of non-functional pancreatic neuroendocrine tumors from pancreatic adenocarcinomas.
Karaman K; Bostanci EB; Aksoy E; Kurt M; Celep B; Ulas M; Dalgic T; Surmelioglu A; Hayran M; Akoglu M
Eur J Intern Med; 2011 Dec; 22(6):e95-8. PubMed ID: 22075321
[TBL] [Abstract][Full Text] [Related]
23. Risk Factors for Pancreatic Cancer in China: A Multicenter Case-Control Study.
Zheng Z; Zheng R; He Y; Sun X; Wang N; Chen T; Chen W
J Epidemiol; 2016; 26(2):64-70. PubMed ID: 26441209
[TBL] [Abstract][Full Text] [Related]
24. Nonhypervascular pancreatic neuroendocrine tumors: Spectrum of MDCT imaging findings and differentiation from pancreatic ductal adenocarcinoma.
Karmazanovsky G; Belousova E; Schima W; Glotov A; Kalinin D; Kriger A
Eur J Radiol; 2019 Jan; 110():66-73. PubMed ID: 30599875
[TBL] [Abstract][Full Text] [Related]
25. National Rise of Primary Pancreatic Carcinoid Tumors: Comparison to Functional and Nonfunctional Pancreatic Neuroendocrine Tumors.
Kasumova GG; Tabatabaie O; Eskander MF; Tadikonda A; Ng SC; Tseng JF
J Am Coll Surg; 2017 Jun; 224(6):1057-1064. PubMed ID: 27965134
[TBL] [Abstract][Full Text] [Related]
26. Chromogranin A is a reliable serum diagnostic biomarker for pancreatic neuroendocrine tumors but not for insulinomas.
Qiao XW; Qiu L; Chen YJ; Meng CT; Sun Z; Bai CM; Zhao DC; Zhang TP; Zhao YP; Song YL; Wang YH; Chen J; Lu CM
BMC Endocr Disord; 2014 Aug; 14():64. PubMed ID: 25099181
[TBL] [Abstract][Full Text] [Related]
27. Insulinoma-associated protein 1 expression in pancreatic neuroendocrine tumours in endoscopic ultrasound-guided fine-needle aspiration cytology: An analysis of 14 patients.
Takase Y; Naito Y; Okabe Y; Ishida Y; Yamaguchi T; Abe H; Murata K; Ito T; Tanigawa M; Kawahara A; Yano H; Akiba J
Cytopathology; 2019 Mar; 30(2):194-200. PubMed ID: 30290028
[TBL] [Abstract][Full Text] [Related]
28. Long-term outcomes in MEN-1 patients with pancreatic neuroendocrine neoplasms: an Israeli specialist center experience.
Oleinikov K; Uri I; Jacob H; Epshtein J; Benson A; Ben-Haim S; Atlan K; Tal I; Meirovitz A; Maimon O; Lev-Cohain N; Mazeh H; Glaser B; Gross DJ; Grozinsky-Glasberg S
Endocrine; 2020 Apr; 68(1):222-229. PubMed ID: 32036501
[TBL] [Abstract][Full Text] [Related]
29. Cystic pancreatic neuroendocrine tumors: outcomes of preoperative endosonography-guided fine needle aspiration, and recurrence during long-term follow-up.
Ridtitid W; Halawi H; DeWitt JM; Sherman S; LeBlanc J; McHenry L; Coté GA; Al-Haddad MA
Endoscopy; 2015 Jul; 47(7):617-25. PubMed ID: 25763832
[TBL] [Abstract][Full Text] [Related]
30. Behavior of Small, Asymptomatic, Nonfunctioning Pancreatic Neuroendocrine Tumors (NF-PNETs).
Jung JG; Lee KT; Woo YS; Lee JK; Lee KH; Jang KT; Rhee JC
Medicine (Baltimore); 2015 Jul; 94(26):e983. PubMed ID: 26131843
[TBL] [Abstract][Full Text] [Related]
31. Prognostic impact of Charlson's Age-Comorbidity Index and other risk factors in patients with pancreatic cancer.
Bagni K; Chen IM; Johansen AZ; Dehlendorff C; Jensen BV; Hansen CP; Preus Hasselby J; Holländer NH; Nissen M; Bjerregaard JK; Pfeiffer P; Yilmaz MK; Rasmussen LS; Nielsen SE; Johansen JS
Eur J Cancer Care (Engl); 2020 May; 29(3):e13219. PubMed ID: 31908093
[TBL] [Abstract][Full Text] [Related]
32. Factors related to gastric neuroendocrine tumors.
Soto-Solís R; Romano-Munive AF; Santana de Anda K; Barreto-Zuñiga R
Rev Gastroenterol Mex (Engl Ed); 2019; 84(1):52-56. PubMed ID: 29705524
[TBL] [Abstract][Full Text] [Related]
33. Molecular alterations in sporadic pancreatic neuroendocrine microadenomas.
Hadano A; Hirabayashi K; Yamada M; Kawanishi A; Takanashi Y; Kawaguchi Y; Nakagohri T; Nakamura N; Mine T
Pancreatology; 2016; 16(3):411-5. PubMed ID: 26905832
[TBL] [Abstract][Full Text] [Related]
34. Diabetes mellitus, other medical conditions and familial history of cancer as risk factors for pancreatic cancer.
Silverman DT; Schiffman M; Everhart J; Goldstein A; Lillemoe KD; Swanson GM; Schwartz AG; Brown LM; Greenberg RS; Schoenberg JB; Pottern LM; Hoover RN; Fraumeni JF
Br J Cancer; 1999 Aug; 80(11):1830-7. PubMed ID: 10468306
[TBL] [Abstract][Full Text] [Related]
35. The association of family history of cancer and medical history with pancreatic cancer risk.
Fehringer G; Gallinger S; Borgida A; Zhang LR; Adams L; Liu G; Hung RJ
Pancreas; 2014 Jul; 43(5):812-4. PubMed ID: 24921205
[No Abstract] [Full Text] [Related]
36. Reassessment of the current American Joint Committee on Cancer staging system for pancreatic neuroendocrine tumors.
Qadan M; Ma Y; Visser BC; Kunz PL; Fisher GA; Norton JA; Poultsides GA
J Am Coll Surg; 2014 Feb; 218(2):188-95. PubMed ID: 24321190
[TBL] [Abstract][Full Text] [Related]
37. Pancreatic neuroendocrine tumour (PNET): Staging accuracy of MDCT and its diagnostic performance for the differentiation of PNET with uncommon CT findings from pancreatic adenocarcinoma.
Kim JH; Eun HW; Kim YJ; Lee JM; Han JK; Choi BI
Eur Radiol; 2016 May; 26(5):1338-47. PubMed ID: 26253257
[TBL] [Abstract][Full Text] [Related]
38. Clinicopathological characteristics of non-functioning cystic pancreatic neuroendocrine tumors.
Nakashima Y; Ohtsuka T; Nakamura S; Mori Y; Nakata K; Miyasaka Y; Ishigami K; Matsuda R; Oda Y; Nakamura M
Pancreatology; 2019 Jan; 19(1):50-56. PubMed ID: 30497875
[TBL] [Abstract][Full Text] [Related]
39. Non-functional pancreatic neuroendocrine tumours: emerging trends in incidence and mortality.
Wu J; Sun C; Li E; Wang J; He X; Yuan R; Yi C; Liao W; Wu L
BMC Cancer; 2019 Apr; 19(1):334. PubMed ID: 30961556
[TBL] [Abstract][Full Text] [Related]
40. Allergies, obesity, other risk factors and survival from pancreatic cancer.
Olson SH; Chou JF; Ludwig E; O'Reilly E; Allen PJ; Jarnagin WR; Bayuga S; Simon J; Gonen M; Reisacher WR; Kurtz RC
Int J Cancer; 2010 Nov; 127(10):2412-9. PubMed ID: 20143395
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
